GDSC Cell Line Gene Expression Profiles Dataset

Description mRNA microarray expression profiles for cancer cell lines
Measurement gene expression by microarray
Association gene-cell line associations by differential expression of gene across cell lines
Category transcriptomics
Resource Genomics of Drug Sensitivity in Cancer
Citation(s)
Last Updated 2015 Apr 06
Stats
  1. 11704 genes
  2. 624 cell lines
  3. 280242 gene-cell line associations

Data Access

API
Script

Visualizations

  • Attribute Similarity

  • Gene Attribute

  • Gene Similarity

cell line Gene Sets

624 sets of genes with high or low expression in each cell line relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.

Gene Set Description
23132-87
5637
639-V disease: carcinoma, transitional cell
647-V
697 Human B cell precursor leukemia; established from the bone marrow of a 12-year-old boy with acute lymphoblastic leukemia (cALL) at relapse in 1979.
786-0 This line was derived from a primary clear cell adenocarcinoma. The karyotype is hypertriploid; Y was present in 60% the cells examined. The cells display both microvilli and desmosomes, and can be grown in soft agar. The cells produce a PTH like peptides that is identical to peptides produced by breast and lung tumors.
8-MG-BA
8505C Established from undifferentiated thyroid carcinomas of a 78 year old female patient.
A101D
A172 A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma. TKG0183(Deposited from Tohoku Univ.).
A204
A2058 Human skin melanoma cell line, established from a 43 years adult caucasian male.
A253
A2780 Human ovarian carcinoma cell line.
A3-KAW
A375
A4-Fuk
A427
A431 Human epidermoid carcinoma established from the solid tumor of an 85-year-old woman; cells were reported to have large numbers of EGF binding sites; cell line was used as indicator cell line for anti-TGF binding.
A498
A549 Human lung carcinoma established from an explanted lung tumor which was removed from a 58-year-old Caucasian man in 1972; cells were described to induce tumors in athymic mice and to synthesize lecithin.
A673
A704 Human kidney adenocarcinoma cell line, established from a 78 years old male.
ABC-1
ACHN
ACN
AGS
ALL-PO
AM-38
AN3-CA
ARH-77 Human plasma cell leukemia cell line, established from the peripheral blood of a 33-year-old woman with IgG plasma cell leukemia; cell line is widely used as model for multiple myeloma/plasma cell leukemia, but cells are clearly EBV+ indicating that ARH-77 might be rather a normal B-lymphoblastoid cell line than a tumor cell line.
AsPC-1
ATN-1 A immortal human blood cell line cell that has the characteristics: Adult T-cell leukemia. HTLV-1 pro-virus DNA(+).
BALL-1 Human acute lymphoblastoid leukemia cell line from peripheral blood.
BB30-HNC
BB49-HNC
BB65-RCC
BC-1
BC-3
BCPAP Human papillary thyroid carcinoma derived cell line.
BE-13
Becker
BEN Human lung carcinoma; established from the supraclavicular tumor cells-containing lymph node of a 71-year-old man with poorly differentiated carcinoma of the lung.
BFTC-905
BFTC-909 disease: carcinoma, transitional cell
BHT-101
BHY Oral squamous cell carcinoma cell line.
BL-41 Human Burkitt lymphoma cell line; established from the tumor tissue of an 8-year-old Caucasian boy with Burkitt lymphoma.
BPH-1 Human benign prostate hyperplasia; prostate epithelial cells from a 68-year-old man with benign prostate hyperplasia; cells were immortalized with SV-40 large T-antigen; cells were described to express cytokeratins 8, 18, and 19 (but not 14) and to metabolize prostatic androgens.
BT-20 Human, Caucasian, breast, carcinoma cell line. Morphology: epithelial-like; species: human, Caucasian female 74 years old; tissue: breast; tumor: carcinoma.
BT-549
BV-173
BxPC-3 Human pancreatic adenocarcinoma cell line, established from a 61 year old human female.
C2BBe1 The C2BBe1 (brush border expressing) cell line was cloned in 1988 from the Caco-2 cell line by limiting dilution.
C32
C3A
Ca-Ski A immortal human uterine cervix-derived cell line cell that has the characteristics: Human cell line derived from uterine cervical epidermoid carcinoma. TKG0366(Deposited from Tohoku Univ.).
CA46
Ca9-22 A immortal human gingiva-derived cell line cell that has the characteristics: Human gingival carcinoma cell line. Expressing remarkable EGF receptor. HLA-A 2/24. TKG0485(Deposited from Tohoku Univ.).
CAKI-1
CAL-120 disease: adenocarcinoma, breast
CAL-12T
CAL-148 disease: adenocarcinoma, breast
CAL-27 Human tongue squamous cell carcinoma established from the poorly differentiated squamous cell carcinoma of the tongue removed from a 56-year-old man before treatment in 1982.
CAL-33 Human tongue squamous cell carcinoma established from the surgically removed fragment of a tongue lesion from a 69-year-old man with moderately differentiated squamous cell carcinoma of the tongue in 1983 (prior to therapy).
CAL-39 disease: carcinoma, squamous cell
CAL-51
CAL-54
CAL-62
CAL-85-1 disease: adenocarcinoma, breast
Calu-3
Calu-6
CAMA-1
Caov-3
Caov-4 disease: adenocarcinoma (ovary primary)
CAPAN-1
CaR-1 Human rectal carcinoma cell line.
CAS-1
CCF-STTG1
CCRF-CEM
CESS
CFPAC-1 This line was derived from a pancreatic duct adenocarcinoma (liver metastasis) from a patient with cystic fibrosis.
CGTH-W-1
ChaGo-K-1
CHL-1
CHP-134 A immortal human adrenal gland-derived cell line cell that has the characteristics: N-myc gene amplification
CHP-212
COLO-205
COLO-320-HSR disease: colorectal adenocarcinoma
COLO-668 disease: carcinoma, oat cell
COLO-678
COLO-679
COLO-680N disease: carcinoma, squamous cell
COLO-684
COLO-741 disease: carcinoma, colon
COLO-792 disease: malignant melanoma
COLO-800
COLO-824
COR-L105
COR-L23 disease: carcinoma, large cell
COR-L279 disease: carcinoma, small cell
COR-L88 disease: carcinoma, lung small cell
CP66-MEL
CP67-MEL
CPC-N disease: carcinoma, small cell
CRO-AP2
CTB-1 A immortal human cell line cell that has the characteristics: Fas-antigen expressing. Ligation with anti-Fas mAb does not induce apoptosis.
CTV-1 disease: leukemia, acute myeloid
CW-2 A immortal human colon-derived cell line cell that has the characteristics: Colon carcinoma. CEA-positive, nude mouse-transplantable.
D-247MG
D-263MG
D-283MED
D-336MG
D-392MG
D-423MG
D-502MG
D-542MG
D-566MG
Daoy The Daoy cell line was established in 1985 by P. F Jacobsen of the Royal Perth Hospital in Western Australia. The line was derived from biopsy material taken from a tumor in the posterior fossa of a 4 year old boy.
Daudi A immortal human blood cell line cell that has the characteristics: Burkitt's lymphoma. Sensitive to lymphokine-activated killer cells but resistant to natural killer cells. Back up culture of ECA3011.
DB disease: large cell lymphoma
DBTRG-05MG
DEL
DG-75
DJM-1 A immortal human zone of skin-derived cell line cell that has the characteristics: Malignant trichilemmal cyst cells. Strongly laminin positive on cell surface. Serum-free culturable.
DK-MG
DMS-114
DMS-273 disease: carcinoma, small cell
DMS-53
DOHH-2
DOK
DoTc2-4510
DSH1
DU-145 A immortal human prostate gland-derived cell line cell that has the characteristics: Human cell line derived from brain metastasis of prostate carcinoma. TKG0604(Deposited from Tohoku Univ.).
DU-4475 disease: ductal carcinoma
EB-3 disease: Burkitts lymphoma
EB2 disease: Burkitts lymphoma (B lymphocyte primary)
EC-GI-10 A immortal human esophagus-derived cell line cell that has the characteristics: Produce hypercalcemia in nude mice. PTH-related protein, IL-1alpha producing.
ECC12 A immortal human stomach-derived cell line cell that has the characteristics: Small cell gastrointestinal carcinoma showing creatine kinase-BB and aromatic L-amino-acid decarboxy. Cell growth is slow.
EFM-19
EFO-21 disease: cystoadenocarcinoma
EFO-27 Human ovary adenocarcinoma cell line; established from the solid omental metastasis of a mucinous papillary adenocarcinoma of the ovary of a 36-year-old woman in 1979.
EGI-1
EHEB Human chronic B cell leukemia cell line;established from the peripheral blood of a 69-year-old woman with B-CLL (chronic lymphocytic leukemia) prior treatment by EBV-transformation in 1988; cell line may represent rather a B-lymphoblastoid cell line than a bona fide B-CLL cell line.
EKVX Non-small cell lung adenocarcinoma cell line.
EM-2 disease: leukemia, chronic myeloid
EoL-1-cell Human eosinophilic leukaemia cell line.
EPLC-272H disease: carcinoma, epidermoid
ES1
ES3
ES5
ES6
ES7
ES8
ESS-1 disease: sarcoma-stromal
ETK-1
EVSA-T
EW-1
EW-11
EW-12
EW-13
EW-16
EW-18
EW-22
EW-24
EW-3
EW-7
FADU Cell line derived from squamous cell carcinoma of the hypopharynx.
FTC-133 Human thyroid carcinoma cell line; obtained from a lymph node metastasis of a follicular thyroid carcinoma from a 42-year-old male.
G-361 Homo sapiens (human); skin; malignant melanoma cell line; established from a 31 year old caucasian male.
G-401 A human cell line derived from a pediatric patient initially classified as Wilm's tumor, reclassified as deriving from a rhabdoid tumor of the kidney
GAK cyclin G associated kinase|In all eukaryotes, the cell cycle is governed by cyclin-dependent protein kinases (CDKs), whose activities are regulated by cyclins and CDK inhibitors in a diverse array of mechanisms that involve the control of phosphorylation and dephosphorylation of Ser, Thr or Tyr residues. Cyclins are molecules that possess a consensus domain called the 'cyclin box.' In mammalian cells, 9 cyclin species have been identified, and they are referred to as cyclins A through I. Cyclin G is a direct transcriptional target of the p53 tumor suppressor gene product and thus functions downstream of p53. GAK is an association partner of cyclin G and CDK5. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]
GAMG Human glioblastoma cell line.
GCIY A immortal human stomach-derived cell line cell that has the characteristics: Stomach cancer (Borrmann IV). Mutin, CA19-9, CEA, alphafetoprotein positive Cell growth is slow.
GCT A Giant Cell Tumor (GCT) cell line derived from a human fibrous histiocytoma lung metastasis
GI-1 A immortal human brain-derived cell line cell that has the characteristics: Human glioma separated from gliosarcoma.
GI-ME-N
GMS-10 disease: glioblastoma
GOTO Human glioblastoma cell line.
GP5d
GR-ST A immortal human blood cell line cell that has the characteristics: RCB1181 ST cells transformed with human G-CSF receptor cDNA. Responds to G-CSF.
GT3TKB
H-EMC-SS disease: chondrosarcoma
H4
H9
HC-1 disease: leukemia, hairy cell
HCC1143 disease: primary ductal carcinoma
HCC1187 disease: primary ductal carcinoma
HCC1395
HCC1419 disease: primary ductal carcinoma
HCC1599 disease: primary ductal carcinoma
HCC1806 disease: primary acantholytic squamous cell carcinoma
HCC1937
HCC1954
HCC2157 disease: primary ductal carcinoma
HCC2218 disease: primary ductal carcinoma
HCC2998
HCC38
HCC70 disease: primary ductal carcinoma
HCE-4 Human esophageal carcinoma cell line.
HCT-116 Human colon colorectal carcinoma cell line from a male organism. Human colon carcinoma cell line; established from the primary colon carcinoma of an adult man.
HCT-15
HD-MY-Z
HDLM-2
HEC-1
HEL Human erythroleukemia, established from the peripheral blood of a 30-year-old man with erythroleukemia (AML M6) in relapse (after treatment for Hodgkin's disease) in 1980; cells were described to be capable of spontaneous and induced globin synthesis.
HGC-27 This human gastric carcinoma cell line was established by culture of the metastatic lymph node from a gastric cancer patient diagnosed histological as undifferentiated carcinoma.
HH
HL-60 Human acute myeloid leukemia established from the peripheral blood of a 35-year-old woman with acute myeloid leukemia (AML FAB M2) in 1976.
HLE Human lens epithelial cell line.
HMV-II A immortal human cell line cell that has the characteristics: Melanin producing. Originated from the same site of HMV-I.
HN Oral squamous cell carcinoma cell line.
HO-1-N-1
HOP-62 Non-small cell lung adenocarcinoma cell line.
HOP-92 Non-small cell lung adenocarcinoma cell line.
HOS
HPAF-II
Hs-578-T
HSC-2 A immortal human mouth-derived cell line cell that has the characteristics: Human cell line derived from oral squamous cell carcinoma occurred in 69-yo, male patient. HLA-A 24/. TKG0487 (Deposited from Tohoku Univ.).
HSC-3 A immortal human tongue-derived cell line cell that has the characteristics: Human tongue squamous cell carcinoma cell line. HLA-A 2/24. TKG0484(Deposited from Tohoku Univ.).
HSC-4 A immortal human tongue-derived cell line cell that has the characteristics: Human tongue squamous cell carcinoma derived cell line. TKG0489 (Deposited from Tohoku Univ.).
HT disease: diffuse mixed lymphoma; B lymphoblast
HT-1080
HT-1197
HT-1376
HT-144 Homo sapiens (human), morphology: fibroblast, tissue: metastatic site: subcutaneous tissue malignant melanoma, established from a 29-year-old caucasian men.
HT-29
HT-3 disease: carcinoma (cervix primary)
HT55
HTC-C3 A immortal human thyroid gland-derived cell line cell that has the characteristics: Secretes IL-1,TGFα,KGM-CSF but not thyroglobulin
HuCCT1 A immortal human cell line cell that has the characteristics: Human bile duct carcinoma. This cell line produces carbohydrate antigen 19/9 in serum-free medium. TKG0389(Deposited from Tohoku Univ.).
HuH-7 HuH-7 is a well differentiated hepatocyte derived cellular carcinoma cell line that was originally taken from a liver tumor in a 57-year-old Japanese male in 1982. The line was established by Nakabayshi, H. and Sato, J. HuH-7 is an immortal cell line of epithelial-like tumorigenic cells. It usually grow in 2D monolayers.
HuO-3N1 A immortal human cell line cell that has the characteristics: Human cell line derived from osteosarcoma. TKG0452(Deposited from Tohoku Univ.).
HuO9
HuP-T3
HuP-T4
HUTU-80
IA-LM A immortal human cell line cell that has the characteristics: Japanese lung large cell carcinoma
IGR-1
IGROV-1
IM-9 Human B lymphoblastoid cell line (from patient with multiple myeloma); established from the bone marrow of a woman with multiple myeloma in 1967. Although derived from the blood of a patient with multiple myeloma, this line has been shown to be an EBV-transformed B lymphoblastoid cell line.
IMR-5
IPC-298
IST-MEL1
IST-MES1 disease: mesothelioma
IST-SL1 disease: carcinoma, small cell
IST-SL2 disease: carcinoma, small cell
J-RT3-T3-5 disease: acute T cell leukemia
J82
JAR
JEG-3
JiyoyeP-2003
JVM-2 disease: leukemia, chronic, B cell
JVM-3 disease: leukemia, chronic, B cell
K5
KALS-1
KARPAS-299
KARPAS-422 Human B cell lymphoma cell line; established from the pleural effusion of a 73-year-old woman with B cell non-Hodgkin lymphoma (intraabdominal, diffuse large cell lymphoma, refractory, terminal) in 1987.
KARPAS-45 disease: leukemia, T cell
KASUMI-1 Human acute myelocytic leukemia cell line; derived from the peripheral blood of a 7-year-old japanese boy with acute myelocytic leukemia in relapse after bone marrow transplantation.
KE-37 Human T cell leukemia cell line; established from a 27-year-old man with acute lymphoblastic leukemia (ALL) in 1979.
KGN A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Granulosa cell tumor. Possible to produce progesterone after HCG addition. Cell growth is slow.
KINGS-1
KM-H2 Human Hodgkin lymphoma cell line, established from the pleural effusion of a 37-year-old man with Hodgkin lymphoma (mixed cellularity progressing to lymphocyte depletion; stage IV at relapse) in 1974.
KM12 Human colon carcinoma cell line.
KMOE-2 disease: erythremia acute
KNS-42
KNS-62
KNS-81-FD
KOSC-2
KP-4 A immortal human cell line cell that has the characteristics: Pancreatic ductal cell carcinoma. Mother cell line of KP4-1, -2, and -3.
KP-N-RT-BM-1
KP-N-YN Human neuroblastoma cell line.
KP-N-YS
KS-1
KU-19-19 disease: carcinoma, transitional cell
KURAMOCHI
KY821
KYSE-140 disease: carcinoma, squamous cell
KYSE-150 Human esophageal squamous cell carcinoma cell line; established from the poorly differentiated esophageal squamous cell carcinoma resected from upper (cervical) esophagus of a 49-year-old Japanese woman after receiving radiotherapy.
KYSE-270 disease: carcinoma, squamous cell
KYSE-410 disease: carcinoma, squamous cell
KYSE-450 disease: carcinoma, squamous cell
KYSE-510 disease: carcinoma, squamous cell
KYSE-520 disease: carcinoma, squamous cell
KYSE-70 disease: carcinoma, squamous cell
L-363 Multiple myeloma cell line expressing syndecan-1.
L-428
L-540
LAMA-84 Human chronic myeloid leukemia in blast crisis; established from the peripheral blood of a 29-year-old woman with chronic myeloid leukemia.
LAN-6
LB1047-RCC
LB2241-RCC
LB2518-MEL
LB373-MEL-D
LB647-SCLC
LB771-HNC
LB831-BLC
LB996-RCC
LC-1F A immortal human cell line cell that has the characteristics: Lung Cancer-1/squamous, floating variant, the same patient as RCB0455 LC-1/sq.
LC4-1 B-precursor acute lymphoblastic leukemia cell line.
LCLC-103H disease: carcinoma, large cell
LCLC-97TM1 disease: carcinoma, large cell
LK-2 A immortal human cell line cell that has the characteristics: Human lung squamous cell carcinoma cell line.TKG0494 (Deposited from Tohoku Univ.).
LN-405
LNCaP-Clone-FGC disease: carcinoma (prostate primary)
LOUCY disease: T lymphocyte; acute lympho- blastic leukemia; t(16;20) translocation
LoVo A immortal human colon-derived cell line cell that has the characteristics: CEA-producing colon adenocarcinoma. Back up culture of ECA2739. Cell growth is slow.
LOXIMVI Human melanoma cell line.
LS-1034 disease: colorectal carcinoma
LS-123
LS-411N disease: colorectal carcinoma
LS-513 disease: colorectal carcinoma
LU-134-A A immortal human cell line cell that has the characteristics: Small cell carcinoma, classic type. See Lu-134-B.
LU-135 A immortal human cell line cell that has the characteristics: Small cell carcinoma, variant type
LU-139 A immortal human cell line cell that has the characteristics: Small cell carcinoma, classic type
LU-65 A immortal human cell line cell that has the characteristics: Human lung carcinoma cell line. TKG0442(Deposited from Tohoku Univ.).
LU-99A
LXF-289
M059J disease: malignant glioblastoma; glioma
M14 The human melanoma cell line M14 has been established from surgically removed melanoma metastases.
MC-IXC
MCF7 A immortal human breast-derived cell line cell that has the characteristics: Human cell line derived from breast adenocarcinoma. TKG0479 (Deposited from Tohoku Univ.).
MDA-MB-157 disease: carcinoma (mammary gland primary)
MDA-MB-175-VII
MDA-MB-231
MDA-MB-361
MDA-MB-415 disease: adenocarcinoma (mammary gland primary)
MDA-MB-453
MDA-MB-468
ME-180 disease: epidermoid carcinoma (cervix primary)
MEG-01
MEL-HO Human melanoma; established from the primary tumor of a woman with melanoma in 1976; cells express mRNA of the oncogene c-myc.
MEL-JUSO Human melanoma, established from the primary tumor of a 58-year-old woman with melanoma in 1977.
MES-SA disease: uterine sarcoma
Mewo Human skin malignant melanoma cell line.
MFE-280
MFE-296
MFH-ino A immortal human cell line cell that has the characteristics: Human fibrous histiocytoma. Showing fibroblastic- and histiocytic features.
MFM-223 Human breast carcinoma; established from the pleural effusion of a post-menopausal breast cancer patient without any prior treatment (tumor: widespread ductal mammary carcinoma T4 N2 M1 with histological grade III); cells were described to express androgen, estrogen and progesterone receptors.
MG-63
MHH-CALL-2 disease: leukemia, pre-B cell
MHH-ES-1
MHH-NB-11
MHH-PREB-1
MIA-PaCa-2 A immortal human cell line cell that has the characteristics: Human cell line derived from pancreatic cancer. TKG0227(Deposited from Tohoku Univ.)
MKN1 A immortal human stomach-derived cell line cell that has the characteristics: Potentially differentiatable to both direction of adenomatous and squamous epithelial cells.
MKN28 Well differentiated human gastric adenocarcinoma cell line.
MKN45 Human gastric adenocarcinoma, established from the poorly differentiated adenocarcinoma of the stomach (medullary type) of a 62-year-old woman.
MKN7 A immortal human stomach-derived cell line cell that has the characteristics: c-erbB-2 expressing gastric adenocarcinoma. Differentiated type.
ML-2
MMAC-SF
MN-60 disease: leukemia, B cell
MOLT-13 Human T cell leukemia cell line; established from the bone marrow of a 2-year-old girl with T-ALL (T cell acute lymphoblastic leukemia, FAB L2) at relapse in 1983.
MOLT-16
MOLT-4
MONO-MAC-6 Human acute monocytic leukemia cell line; established from the peripheral blood of a 64-year-old man with relapsed acute monocytic leukemia (AML FAB M5) in 1985 following myeloid metaplasia. Sister cell line of MONO-MAC-1.
MPP-89 disease: mesothelioma
MRK-nu-1 Human mammary gland carcinoma cell line, established from a 46 years old female.
MS-1
MSTO-211H Human mesothelioma cell line; established from the pleural effusion of a 62-year-old Caucasian man with mesothelioma (malignant biphasic) who did not have any prior therapy.
MZ2-MEL
MZ7-mel
NALM-6
NB10
NB12
NB13
NB14 Human neuroblastoma tumor cell line.
NB17
NB5 Human neuroblastoma tumor cell line.
NB6
NB69 A immortal somatic nervous system-derived cell line cell that has the characteristics: N-myc gene unamplified tumor. Cell growth is slow.
NB7 Human neuroblastoma cell line.
NBsusSR A immortal human cell line cell that has the characteristics: Isolated from a patient with hiper dopaminemia andnorepinephrinemia.
NCI-H1048 disease: carcinoma; small cell lung cancer (lung primary)
NCI-H1092 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H1155
NCI-H1299
NCI-H1355
NCI-H1395
NCI-H1437
NCI-H1563 disease: adenocarcinoma; non-small cell lung cancer
NCI-H1573 disease: adenocarcinoma (lung primary)
NCI-H1650
NCI-H1666 disease: adenocarcinoma; bronchoalveolar carcinoma (lung primary)
NCI-H1693 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H1703
NCI-H1755 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H1770 disease: neuroendocrine carc- cinoma; non-small cell lung cancer (lung primary)
NCI-H1792 disease: adenocarcinoma (lung primary)
NCI-H1793 disease: adenocarcinoma; non-small cell lung cancer
NCI-H1838 disease: adenocarcinoma; non-small cell lung cancer
NCI-H1975
NCI-H1993 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H2009
NCI-H2029 disease: carcinoma; small cell lung cancer (lung primary)
NCI-H2030 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H2052 disease: mesothelioma (pleura primary)
NCI-H2081 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H2087
NCI-H209 Small cell lung cancer cell line.
NCI-H2126
NCI-H2141 disease: carcinoma; small cell lung cancer (lung primary)
NCI-H2170
NCI-H2171 disease: carcinoma; small cell lung cancer (lung primary)
NCI-H2196 disease: carcinoma; small cell lung cancer (lung primary)
NCI-H2227 disease: carcinoma; small cell lung cancer
NCI-H2228 disease: adenocarcinoma; non-small cell lung cancer
NCI-H226
NCI-H2291 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H23
NCI-H2342 disease: adenocarcinoma; non-small cell lung cancer
NCI-H2347
NCI-H2405 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H2452 disease: mesothelioma
NCI-H250 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H28 disease: mesothelioma (pleura primary)
NCI-H292 Mucoepidermoid human lung carcinoma cell line; established from a black female 32 years old; Morphology: epithelial.
NCI-H345 Small cell lung cancer cell line.
NCI-H358
NCI-H378 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H441
NCI-H446 disease: carcinoma; small cell lung cancer (lung primary)
NCI-H460
NCI-H510A disease: carcinoma; small cell lung cancer (unknown primary)
NCI-H520
NCI-H522
NCI-H524
NCI-H526 Human small cell lung cancer cell line; established from a 55 years old caucasian male.
NCI-H596 Human lung adenosquamous carcinoma cell line; derived in 1983 from a tumor mass in the chest wall of a patient with adenosquamous carcinoma of the lung.
NCI-H630 disease: carcinoma (rectum primary)
NCI-H64
NCI-H650 disease: bronchioalveolar carci- noma; non-small cell lung cancer (lung primary)
NCI-H661
NCI-H716
NCI-H727 disease: carcinoid
NCI-H747 disease: colorectal adenocarcinoma
NCI-H810 disease: large cell; neuroendocrine; carcinoma; non-small cell lung cancer
NCI-H82
NCI-H838
NCI-N87
NCI-SNU-1
NCI-SNU-16
NCI-SNU-5
NEC8 A immortal human testis-derived cell line cell that has the characteristics: Embryonal carcinoma, testis.
NH-12 A immortal somatic nervous system-derived cell line cell that has the characteristics: Human cell line derived from neuroblastoma. TKG0448(Deposited from Tohoku Univ.).
NKM-1
NMC-G1
no-10
no-11
NOMO-1
NOS-1 A immortal human bone element-derived cell line cell that has the characteristics: Osteoid producing in vitro and in nude mice. Cell growth is slow.
NUGC-3 Human gastric adenocarcinoma cell line established from a 72-year-old male.
NY
OAW-28
OAW-42 disease: cystoadenocarcinoma
OC-314 disease: cystoadenocarcinoma, low differentiated, papillary serous; G2/3 FIGO stage III c
OCI-AML2 Human acute myeloid leukemia cell line; established from the peripheral blood of a 65-year-old man with acute myeloid leukemia.
OCUB-M A immortal human mammary gland-derived cell line cell that has the characteristics: Same as OCUB-1, OCUB-F. Chromosome = pseudotetraploid.
OE19
OE33
OMC-1 A immortal human uterine cervix-derived cell line cell that has the characteristics: Japanese cervix squamous cell carcinoma. Once said TA-4 positive.
ONS-76
OPM-2
OS-RC-2 A immortal human kidney-derived cell line cell that has the characteristics: Renal tumor cell from a Japanese. Transplantable to nude mice.
OVCAR-3
OVCAR-4
OVCAR-5
OVCAR-8
P12-ICHIKAWA Human T cell leukemia; established from the peripheral blood of a 7-year-old boy with acute lymphoblastic leukemia (ALL).
P30-OHK A immortal human blood cell line cell that has the characteristics: Human cell line derived from T cell leukemia. TKG0463(Deposited from Tohoku Univ.).
P31-FUJ
PA-1 Human ovary ascites teratocarcinoma cell line. The line was established from cells taken from ascitic fluid.
PANC-03-27
PANC-08-13
PANC-10-05 disease: adenocarcinoma; same patient as PL45
PC-14
PC-3
PF-382
PFSK-1 disease: malignant primitive neuroectodermal tumor
PSN1 Human pancreatic adenocarcinoma cell line.
QIMR-WIL disease: leukemia, myeloblastic
Raji
Ramos-2G6-4C10 disease: Burkitts lymphoma (American)
RCC10RGB A immortal human kidney-derived cell line cell that has the characteristics: Kidney carcinoma from a Japanese patient. Cell growth is slow.
RCM-1
RD
REH Human B cell precursor leukemia established from the peripheral blood of a 15-year-old North African girl with acute lymphoblastic leukaemia, ALL at first relapse, in 1973.
RERF-LC-MS
RH-1 Human rhabdomyosarcoma cell line.
RH-18 Human rhabdomyosarcoma cell line.
RKO
RL
RMG-I Human tumor cell line from ovarian mesonephroid adenocarcinoma.
RO82-W-1
RPMI-2650 Human nasal septum squamous cell carinoma cell line; established from the pleural effusion of a 52-year-old man with anaplastic squamous cell carcinoma of the nasal septum in 1962.
RPMI-6666 disease: Hodgkins disease
RPMI-7951 Human skin malignant melanoma cells that can be ordered from ATCC. This is a hyperdiploid human cell line with the modal chromosome number of 49, occurring in 24% of cells. Polyploid cells occurred at 22%, which is high. Cells are adherent, and were first harvested in 1971 from a metastatic site in a lymph node.
RPMI-8226
RPMI-8402 Human T cell acute lymphoblastic leukemia cell line; established from the peripheral blood of a 16-year-old woman with acute lymphoblastic leukemia (ALL) in 1972.
RPMI-8866 Human B lymphoid cell line, established from the peripheral blood of a 51-year-old American woman with chronic myelogenous leukemia in May 1966.
RS4-11 Human B cell precursor leukemia cell line; established from the bone marrow of a 32-year-old woman with acute lymphoblastic leukemia (ALL L2) in first relapse.
RT-112 Human urinary bladder transitional cell carcinoma established from the transitional cell carcinoma histological grade G2 excised from a female patient with untreated primary urinary bladder carcinoma in 1973.
RVH-421
RXF393 Renal cancer cell line.
S-117
Saos-2 Human osteogenic sarcoma, established from the primary osteogenic sarcoma of an 11-year-old Caucasian woman in 1973.
SAS A immortal human tongue-derived cell line cell that has the characteristics: Human cell line derived from tongue cancer. Squamous cell carcinoma. TKG0470(Deposited from Tohoku Univ.).
SBC-1 Human small cell lung cancer cell line.
SBC-5
SCC-15 Human tongue squamous cell carcinoma cell line.
SCC-25 Human squamous cell carcinoma cell line; established from the biopsy of a squamous cell carcinoma of the tongue of a 70-year-old man.
SCC-3
SCC-4 Human squamous cell carcinoma cell line; established from the squamous cell carcinoma of the tongue from a 55-year-old man after radio- and chemotherapy in 1980.
SCC-9 disease: squamous cell carcinoma
SCH
SF126
SF268
SF295
SF539
SHP-77
SiHa
SIMA
SJRH30 disease: rhabdomyosarcoma (muscle primary)
SJSA-1
SK-CO-1 disease: colorectal adenocarcinoma (colon primary)
SK-HEP-1 Human liver adenocarcinoma cell line; established from the ascites of a 52-year-old Caucasian man in 1971.
SK-LMS-1
SK-LU-1 Non-small cell lung cancer cell line.
SK-MEL-2
SK-MEL-24 disease: malignant melanoma
SK-MEL-28
SK-MEL-3
SK-MEL-30 Human melanoma derived from tumor tissue (subcutis metastasis) of a 67-year-old Caucasian man with malignant melanoma in 1975.
SK-MEL-5 Human caucasian skin melanoma cell line; established from a 24 year old Caucasian female. Derived from: axillary node.
SK-MES-1
SK-MG-1
SK-MM-2
SK-N-AS
SK-N-DZ Neuroblastoma cell line derived in 1978 from a bone marrow metastasis from a 2 years old caucasian female child with poorly differentiated embryonal neuroblastoma.
SK-N-FI Neuroblastoma cell line; derived in 1979 from a bone marrow metastasis from a 11 year old Caucasian male with poorly differentiated embryonal neuroblastoma.
SK-NEP-1 disease: Wilmstumor (kidney primary)
SK-OV-3
SK-UT-1
SKG-IIIa A immortal human uterine cervix-derived cell line cell that has the characteristics: Cervical carcinoma cell line derived from human. TA-4, CA-4, TPA, placental ALP are positive. Regan isoenzyme producing. p53 normal, p51 mutation (+), HLA-A 2402/.TKG0462(Deposited from Tohoku Univ.).
SKM-1
SN12C Human renal cell carcinoma cell line.
SNG-M
SNU-387
SNU-423
SNU-449
SNU-475
SNU-C1 disease: adenocarcinoma colon primary)
SNU-C2B disease: colorectal carcinoma
SR
ST486 disease: Burkitts lymphoma
SU-DHL-1
SUP-T1 Human T cell lymphoma cell line; established from the pleural effusion of an 8-year-old boy with T-lymphoblastic lymphoma in relapse.
SW1088
SW1116
SW13
SW1417
SW1463
SW1573
SW1710 disease: carcinoma, transitional cell
SW1783 disease: astrocytoma
SW1990
SW48
SW620
SW626 Human, ovary, adenocarcinoma cell line.
SW684 disease: fibrosarcoma
SW780 disease: transitional cell carcinoma
SW837
SW872
SW900
SW948
SW954 disease: squamous cell carcinoma
SW962 disease: carcinoma (vulva primary)
SW982 disease: synovial sarcoma
T-24
T47D
T84
T98G A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma multiforme (Caucasian). Hyperpentaploid chromosome count. TKG0471(Deposited from Tohoku Univ.).
TALL-1 A immortal human bone marrow-derived cell line cell that has the characteristics: Human T-cell line derived from acute lynphblastic leukemia. TKG0251 (Deposited from Tohoku Univ.).
TC-YIK A immortal human uterine cervix-derived cell line cell that has the characteristics: Integrating HPV16, neurosecretory granules(+)
TCCSUP disease: transitional cell carcinoma
TE-1 A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Squamous cell carcinoma. TKG0462(Deposited from Tohoku Univ.).
TE-10 A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0261(Deposited from Tohoku Univ.).
TE-11 A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0262(Deposited from Tohoku Univ.).
TE-12
TE-15 Human esophageal squamous cell carcinoma cell line.
TE-5 A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from poorly differntiated esophageal squamous cell carcinoma. Not transplantable to nude mouse. TKG0256 (Deposited from Tohoku Univ.).
TE-6 A immortal human esophagus-derived cell line cell that has the characteristics: Highly differentiated squamous carcinoma (esophagus), not transplantable to nude mouse.  A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cyclin and MC210. TKG0257 (Deposited from Tohoku Univ.).
TE-8 A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0259(Deposited from Tohoku Univ.).
TE-9 A immortal human esophagus-derived cell line cell that has the characteristics: Human esophageal squamous cell carcinoma (poorly differentiated) cell line. Not transplantable to nude mouse. TKG0260 (Deposited from Tohoku Univ.).
TGBC11TKB A immortal human stomach-derived cell line cell that has the characteristics: Japanese gastric cancer, lymph node metastated.
TGBC1TKB A immortal human cell line cell that has the characteristics: Japanese gallbadder carcinoma metastated to lymph node from the same patient of TGBC2TKB. Cell growth is slow.
TGBC24TKB A immortal human cell line cell that has the characteristics: Japanese gallbladder carcinoma established from metastated ascite. Cell growth is slow.
TGW
TK10 TK-10 was derived from a specimen of primary RCC obtained following a left radical nephrectomy in a 43-year-old male on August 21, 1980.
TT
TUR disease: histiocytic lymphoma; neomycin resistant
TYK-nu
U-118-MG Human neuronal glioblastoma (grade III) cell line.
U-2-OS
U-266 Human multiple myeloma cell line; established from the peripheral blood of a 53-year-old man with IgE-secreting myeloma (refractory, terminal) in 1968.
U-698-M disease: lymphoma, B cell
U-87-MG Human, Caucasian, brain, glioblastoma-astrocytoma cell line Morphology: epithelial-like; Species: human, Caucasian female 44 years old; Tissue: brain; Tumor: glioblastoma-astrocytoma.
U031
U251 Human glioma cell line. Morphology: glial; Species: human; Tumor: glioma.
UACC-257
UACC-62
UACC-812 disease: ductal carcinoma
UM-UC-3
UMC-11 disease: carcinoid
VA-ES-BJ disease: carcinoma, epithelioid (bone primary)
VM-CUB-1 disease: carcinoma, transitional cell
VMRC-RCZ Human renal carcinoma cell line.
WM-115
WSU-NHL
YAPC
YH-13
YKG-1 A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma. TKG0453(Deposited from Tohoku Univ.).
ZR-75-30